These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23547842)

  • 1. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.
    Wei X; Senanayake TH; Warren G; Vinogradov SV
    Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
    Wei X; Senanayake TH; Bohling A; Vinogradov SV
    Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
    Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
    Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
    Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
    Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells.
    Li F; Bae BC; Na K
    Bioconjug Chem; 2010 Jul; 21(7):1312-20. PubMed ID: 20586473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
    Yang C; Li C; Zhang P; Wu W; Jiang X
    Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid and hyaluronic acid: Sucrose nanogels for hydrophobic cancer drug delivery.
    Sagbas Suner S; Ari B; Onder FC; Ozpolat B; Ay M; Sahiner N
    Int J Biol Macromol; 2019 Apr; 126():1150-1157. PubMed ID: 30625351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo.
    Wang J; Li Y; Wang L; Wang X; Tu P
    Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
    Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
    Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
    Vinogradov SV; Kohli E; Zeman AD
    Pharm Res; 2006 May; 23(5):920-30. PubMed ID: 16715382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermoresponsive hyaluronic acid nanogels as hydrophobic drug carrier to macrophages.
    Fernandes Stefanello T; Szarpak-Jankowska A; Appaix F; Louage B; Hamard L; De Geest BG; van der Sanden B; Nakamura CV; Auzély-Velty R
    Acta Biomater; 2014 Nov; 10(11):4750-4758. PubMed ID: 25110287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer.
    Cao Z; Li W; Liu R; Li C; Song Y; Liu G; Chen Y; Lu C; Lu A; Liu Y
    Int J Nanomedicine; 2020; 15():8369-8382. PubMed ID: 33149581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation and pH-responsive release of bortezomib by dopamine grafted hyaluronate nanogels.
    Liu L; Luan S; Zhang C; Wang R; Zhang Y; Zhang M; Sheng Q; Han G; Wang T; Song S
    Int J Biol Macromol; 2021 Jul; 183():369-378. PubMed ID: 33932413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Sensitive Coiled-Coil Peptide-Cross-Linked Hyaluronic Acid Nanogels: Synthesis and Targeted Intracellular Protein Delivery to CD44 Positive Cancer Cells.
    Ding L; Jiang Y; Zhang J; Klok HA; Zhong Z
    Biomacromolecules; 2018 Feb; 19(2):555-562. PubMed ID: 29284258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
    Tan S; Yamashita A; Gao SJ; Kurisawa M
    Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation.
    Seok HY; Sanoj Rejinold N; Lekshmi KM; Cherukula K; Park IK; Kim YC
    J Control Release; 2018 Jun; 280():20-30. PubMed ID: 29723613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates.
    Senanayake TH; Warren G; Wei X; Vinogradov SV
    J Control Release; 2013 Apr; 167(2):200-9. PubMed ID: 23385032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid/poly(β-amino ester) polymer nanogels for cancer-cell-specific NIR fluorescence switch.
    Park HS; Lee JE; Cho MY; Hong JH; Cho SH; Lim YT
    Macromol Rapid Commun; 2012 Sep; 33(18):1549-55. PubMed ID: 22753358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects.
    Liu R; Hou W; Li J; Gou X; Gao M; Wang H; Zhang Y; Deng H; Yang X; Zhang W
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132074. PubMed ID: 38705320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.